AUGMENTATION OF ANDROGEN‐RECEPTOR BINDING IN VITRO: STUDIES IN NORMALS AND PATIENTS WITH ANDROGEN INSENSITIVITY
- 1 November 1985
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 23 (5), 567-577
- https://doi.org/10.1111/j.1365-2265.1985.tb01117.x
Abstract
Using a simple whole‐cell binding assay, the effect of androgens on receptor binding activity was studied in genital skin fibroblasts (GSF) from normals and patients with either androgen insensitivity syndrome (AIS), isolated micropenis or hypospadias. Expressing the response as a ratio of augmented to basal specific dihydrotestosterone (DHT) binding, there was a 2.4±0.87 (mean±SD) increase following 20 h incubation with 2 nmol/1 [3H] ‐DHT in normal GSF. Mibolerone, a synthetic nonmetabolizable androgen, produced a similar response. Augmentation was temperature dependent, independent of androgen metabolism and suppressed by protein and RNA inhibitors. All patients with isolated micropenis and hypospadias demonstrated normal augmentation of receptor binding activity. There was no response in patients with complete AIS who were receptor negative. In the majority of patients with partial AIS, there was an in vitro response to androgens; those reared as males all virilized with androgen therapy. In contrast, a male patient with partial AIS who failed to respond to high‐dose androgen therapy, showed no augmentation of specific androgen binding in GSF preincubated with androgens. This technique may be a useful in vitro bioassay to predict androgen responsiveness in vivo in patients with androgen insensitivity, either soon after birth in the short‐term, or later at puberty.Keywords
This publication has 27 references indexed in Scilit:
- Steroid hormone action in eucaryotic cells.JCI Insight, 1984
- Familial external genital ambiguity due to a transformation defect of androgen-receptor complexes that is expressed with 5α-dihydrotestosterone and the synthetic androgen methyltrienoloneAmerican Journal of Medical Genetics, 1984
- A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.JCI Insight, 1984
- Androgen stimulated elevation in androgen receptor levels is inhibited by the synthetic glucocorticoid triamcinolone acetonideBiochemical and Biophysical Research Communications, 1983
- Regulation of the androgen receptor by androgen in normal and androgen-resistant genital skin fibroblastsThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Defective activation of androgen-receptor complexes a marker of androgen insensitivityMolecular and Cellular Endocrinology, 1982
- Defective up-regulation of the androgen receptor in human androgen insensitivityNature, 1981
- The Syndromes of Androgen ResistanceNew England Journal of Medicine, 1980
- CELL CYCLE EVENTS IN THE HYDROCORTISONE REGULATION OF ALKALINE PHOSPHATASE IN HELA S3 CELLSThe Journal of cell biology, 1969
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949